Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonora

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 9, 2022
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIVM Barale, M Massano, F Bioletto, et al.
International Journal of Antimicrobial Agents|January 29, 2020
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic SupplementationC Montrucchio, A De Nicolò, G D'Ettorre, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failureA Calcagno, N Pagani, A Ariaudo, et al.
British Journal of Clinical Pharmacology|February 15, 2018
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administrationA Calcagno, C Pinnetti, A De Nicolò, et al.
The Journal of Infectious Diseases|May 1, 1995
Pentoxifylline as a supportive agent in the treatment of cerebral malaria in childrenG Di Perri, I G Di Perri, G B Monteiro, et al.
The Pharmacogenomics Journal|November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?A Calcagno, M Fiumanò, D Zugna, et al.
Transplantation Proceedings|September 27, 2005
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantationG Guaraldi, S Cocchi, M Codeluppi, et al.
Virology Journal|June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller womanL Di Girolamo, M Ferrara, G Trevisan, et al.
Journal of Neurovirology|July 7, 2017
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?S Mornese Pinna, E Scarvaglieri, M G Milia, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virusD Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 9, 2022
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIVM Barale, M Massano, F Bioletto, et al.
International Journal of Antimicrobial Agents|January 29, 2020
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic SupplementationC Montrucchio, A De Nicolò, G D'Ettorre, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failureA Calcagno, N Pagani, A Ariaudo, et al.
British Journal of Clinical Pharmacology|February 15, 2018
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administrationA Calcagno, C Pinnetti, A De Nicolò, et al.
The Journal of Infectious Diseases|May 1, 1995
Pentoxifylline as a supportive agent in the treatment of cerebral malaria in childrenG Di Perri, I G Di Perri, G B Monteiro, et al.
The Pharmacogenomics Journal|November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?A Calcagno, M Fiumanò, D Zugna, et al.
Transplantation Proceedings|September 27, 2005
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantationG Guaraldi, S Cocchi, M Codeluppi, et al.
Virology Journal|June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller womanL Di Girolamo, M Ferrara, G Trevisan, et al.
Journal of Neurovirology|July 7, 2017
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?S Mornese Pinna, E Scarvaglieri, M G Milia, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virusD Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Pageof 11